Free Trial
NASDAQ:SCNX

Scienture Q1 2025 Earnings Report

Scienture logo
$0.36 -0.02 (-5.26%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$0.37 +0.01 (+3.89%)
As of 06/5/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Scienture EPS Results

Actual EPS
-$0.33
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Scienture's next earnings date is estimated for Monday, August 17, 2026, based on past reporting schedules.

Conference Call Resources

Scienture Earnings Headlines

Scienture (NASDAQ:SCNX) Trading Down 5.3% - Time to Sell?
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel
Scienture Holdings Inc SCNX
See More Scienture Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

Scienture (NASDAQ:SCNX) engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

View Scienture Profile